Upload
lytu
View
220
Download
3
Embed Size (px)
Citation preview
SUPPORTING INFORMATION
Design, synthesis, in silico and in vitro evaluation of novel pyrimidine phosphonate molecule
revealed potential cytotoxicity against breast cancer cells
Nanda kumar Yellapu1#. Navya Atluri2#. Kalpana Kandlapalli3a. Raveendrababu Killaru. Jhansi Rani Vangavaragu4. Hariprasad Osuru5.
Sarma PVGK3b. Bhaskar Matcha1*
1Division of Animal Biotechnology, Department of Zoology, Sri Venkateswara University, Tirupati – 517 502, India
2Department of Applied Microbiology, Sri Padmavati Mahila Visvavidyalayam, Tirupati – 517502, Andhra Pradesh, India
3aDepartment of Biochemistry & 3bDepartment of Biotechnology, Sri Venkateswara Institute of Medical Sceicnes, Tirupati – 517507, Tirupati,
India
4Department of Pharmacology and Toxicology, University of Kansas, Lawrence, KS 66047 – USA
5Department of Pathology, University Of Virginia, Charlottesville, Virginia – USA
List of Contents----------------------------------------------------------------------------------------------------------------------------------page No.
1. ADME properties predicted for compounds 6a-6i…………………………………………………………………...……………….S2
2. Molecular docking interaction of 6a-6i with aromatase active site…………………………………………………………….....S3-S4
3. 1H NMR, 13C NMR, 31P NMR spectra’s and HRMS spectra for compound 6i………………………………………………….S5-S8
S1
Compound
Human intestinal
absorption (%)
in vitro Caco-2 cell permeability
(nm/sec)
in vitro MDCK cell
permeability (nm/sec)
in vitro skin permeability
(logKp, cm/hour)
in vitro plasma protein
binding (%)
in vivo blood-brain barrier penetration
([brain]/[blood])6a 65.21 1.18 0.34 -3.14 85.61 0.516b 60.38 0.39 1.02 -3.59 72.87 0.446c 80.82 0.57 1.50 -4.06 51.69 0.366d 78.32 0.54 2.11 -4.25 23.57 0.406e 56.36 0.39 1.46 -3.84 48.24 0.426f 56.36 0.39 0.92 -3.84 43.89 0.426g 90.71 2.97 0.51 -3.95 44.80 0.506h 91.93 3.14 0.41 -3.67 66.44 0.526i 85.04 14.82 0.39 -3.46 69.57 0.27
Table S1: ADME properties predicted for the compounds 6a-6i.
S2
6a 6b 6c
6d 6e 6f
S3
6g 6h 6i
Exemestane
Table S2: Molecular docking interaction of compounds 6a-6i in the Aromatase active site.
S4
PO
O
O
O
NH
N
O
O
O
OH
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5f1 (ppm)
2.96
5.99
2.85
0.29
3.99
8.02
0.99
0.94
2.01
1.94
0.98
1.00
1.09
1.10
1.10
1.12
1.21
1.21
1.22
1.22
1.23
1.24
1.25
1.99
2.24
2.50
DM
SO2.
50 D
MSO
2.50
DM
SO2.
51 D
MSO
2.51
DM
SO2.
732.
732.
89
3.35
3.88
3.90
3.97
3.99
4.03
4.03
4.04
4.04
4.06
4.07
5.09
5.10
5.76
5.76
6.87
6.88
6.89
6.89
6.90
7.13
7.13
7.14
7.15
7.15
7.68
7.68
7.69
7.69
9.16
9.17
S5
N
NH
O
O
O
HO
O
PO
OO
C-8C-4
C-5
C-1 C-2C-3
C-6
C-7
C-9
C-10
C-11
C-12
C-13
C-14
C-15
C-16
C-17
C-18
C-19C-20
C-21
102030405060708090100110120130140150160170f1 (ppm)
14.0
516
.21
16.2
617
.71
53.2
754
.87
59.1
061
.66
61.7
163
.45
64.7
466
.67
66.8
370
.79
70.8
8
99.4
799
.49
114.
16
127.
37
137.
15
148.
00
152.
10
157.
51
165.
31
S6
-240-220-200-180-160-140-120-100-80-60-40-20020406080100120140f1 (ppm)
1.00
21.8
921
.91
S7
S8